When shopping for cannabis, most people are familiar with the terms indica, sativa, and hybrid. These labels appear on flower, pre-rolls, vapes, and other cannabis products. However, scientists also use another system to describe cannabis based on its chemical composition: cannabis chemotypes.
Rather than focusing on a plant’s name, appearance, or traditional classification, chemotypes describe the types and proportions of cannabinoids the plant produces.
The three classic categories are Type I, Type II, and Type III. Each represents a different relationship between THC and CBD.
Understanding these categories can help consumers interpret product labels and recognize why two cannabis cultivars may have very different cannabinoid profiles.
What Are Cannabis Chemotypes?
A chemotype is a way of classifying a plant according to its chemical characteristics.
For cannabis, the traditional chemotype system focuses primarily on the relative amounts of THC and CBD the plant can produce.
Scientists commonly recognize three major groups:
- Type I: THC-dominant cannabis
- Type II: Cannabis with a relatively balanced THC-to-CBD ratio
- Type III: CBD-dominant cannabis
This classification focuses on chemical composition rather than the plant’s shape or its marketed strain name.
Researchers also recognize additional cannabinoid profiles, including CBG-dominant plants. However, Types I, II, and III remain the foundation of the traditional system. PMC+1
Type I Cannabis: THC-Dominant
Type I cannabis produces substantially more THC than CBD.
This is the chemical profile commonly associated with many adult-use cannabis flower products.
For example, a cultivar containing a relatively high concentration of THC and very little CBD would generally fall into this category.
However, Type I doesn’t specify an exact THC percentage.
Two Type I cultivars may contain very different concentrations of THC while sharing the same general chemical classification.
Therefore, identifying a product as Type I doesn’t automatically tell you how potent it is.
Type II Cannabis: Balanced THC and CBD
Type II cannabis contains meaningful amounts of both THC and CBD, often in relatively similar proportions.
Products associated with this category may be described as balanced or approximately 1:1 THC-to-CBD formulations.
However, a product marketed with a 1:1 ratio isn’t necessarily made from a Type II plant. Manufacturers can also create balanced formulations by blending separately sourced cannabinoids.
This distinction matters because a plant’s chemotype and a finished product’s formulation aren’t always the same thing.
Type II classification describes the plant’s natural cannabinoid production, while a balanced product label describes the composition of the product being sold.
Type III Cannabis: CBD-Dominant
Type III cannabis produces substantially more CBD than THC.
These cultivars are often associated with CBD-focused hemp breeding programs, although the botanical chemotype itself is not a complete legal classification.
A CBD-dominant plant can still contain some THC.
Therefore, consumers shouldn’t assume that every Type III product is entirely THC-free.
The exact cannabinoid concentrations remain important, particularly for people who want to limit THC exposure.
Why THC and CBD Ratios Matter
The relationship between THC and CBD provides information that a single potency number cannot.
For example, imagine two cannabis products with the same total cannabinoid percentage.
One may contain predominantly THC, while the other contains a mixture of THC and CBD.
Although the total cannabinoid numbers may look similar, their chemical compositions differ.
This is why cannabinoid ratios are useful when comparing products.
However, the ratio alone doesn’t predict how someone will respond. Dose, consumption method, individual sensitivity, and other factors still matter.
Chemotypes vs. Indica and Sativa
Traditional indica and sativa labels don’t directly describe a product’s cannabinoid ratio.
A product labeled indica can be THC-dominant, just as a product labeled sativa can be THC-dominant.
The labels describe different classification approaches.
Indica, sativa, and hybrid are commonly used commercial categories.
Chemotypes describe the plant’s chemical profile, particularly its THC-to-CBD relationship.
As a result, chemotypes can provide a more direct way to understand cannabinoid composition.
However, they don’t replace the need to review a product’s full laboratory information.
Are There More Than Three Cannabis Chemotypes?
Yes.
As cannabis breeding and analytical testing have advanced, researchers have identified additional chemical categories.
For example, Type IV generally describes CBG-dominant cannabis, while Type V refers to plants producing little or no detectable cannabinoids.
These additional categories demonstrate how cannabis breeding extends beyond simply maximizing THC or CBD.
Still, the terminology can vary between research publications, and the three-category system remains widely recognized.
What Does Scientific Research Say?
A 2026 study published in Plant Direct examined the genetic basis of cannabis chemotype classification.
The researchers describe the traditional categories as THC-dominant, intermediate THC/CBD, and CBD-dominant. Their work also examines how genes involved in cannabinoid production help determine these chemical differences. PMC
Read the research: The Structure of the Chemotype Determining Locus in Cannabis sativa.
Additional research examining commercial cannabis products has shown that cannabinoid and terpene profiles can reveal chemical differences that aren’t captured by conventional product labels. PMC
These findings reinforce the value of understanding cannabis through its measurable chemistry.
How Chemotypes Relate to Cannabis Genetics
Cannabinoid production is strongly influenced by genetics.
Different cannabis plants inherit genes that affect the enzymes responsible for producing cannabinoid acids such as THCA and CBDA.
As a result, breeders can select plants with particular cannabinoid profiles and develop lines that emphasize those characteristics.
However, environmental conditions and cultivation practices can also influence the concentrations ultimately measured in harvested flower.
For more information about how genetics and growing conditions influence cannabis characteristics, read our guide to cannabis phenotypes and why the same strain can look different.
Do Chemotypes Predict Cannabis Effects?
Not precisely.
Chemotypes provide valuable information about cannabinoid composition, but they don’t fully predict an individual’s experience.
Two THC-dominant products may differ in total THC content, minor cannabinoids, terpenes, and formulation.
Likewise, two products with similar THC-to-CBD ratios may deliver different amounts of cannabinoids per serving.
This is why consumers should consider several details together:
- THC and CBD content
- Cannabinoid ratio
- Serving size
- Product format
- Laboratory information
- Personal tolerance
Chemotype classification is a useful starting point, not a complete prediction of effects.
Why Cannabis Chemotypes Matter When Shopping
Understanding chemotypes encourages consumers to look beyond a single THC percentage.
Instead of assuming every cannabis product belongs neatly within an indica or sativa category, shoppers can consider the actual cannabinoids present.
This approach is particularly helpful when comparing THC-dominant flower, balanced cannabinoid products, and CBD-focused formulations.
It also highlights why accurate product labeling and laboratory testing matter.
At Orange County Cannabis Co., our goal is to help consumers understand the terminology behind the products they encounter.
Final Thoughts on Cannabis Chemotypes
Cannabis chemotypes provide a scientific way to classify cannabis according to cannabinoid composition.
Type I describes THC-dominant cannabis, Type II describes a more balanced THC-to-CBD profile, and Type III describes CBD-dominant cannabis.
Although additional categories exist, these three groups remain an important foundation for understanding cannabis chemistry.
Most importantly, chemotypes don’t automatically determine potency, quality, or effects.
By considering cannabinoid ratios alongside product testing, serving size, and personal preferences, consumers can make more informed decisions.
At Orange County Cannabis Co., we believe education helps make cannabis shopping clearer, more approachable, and more transparent.
